Medpace Holdings Inc

01P

Company Profile

  • Business description

    Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

  • Contact

    5375 Medpace Way
    CincinnatiOH45227
    USA

    T: +1 513 579-9911

    E: [email protected]

    https://www.medpace.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    6,500

Stocks News & Analysis

stocks

ASX share undervalued despite solid growth

First-quarter performance exceeds expectations.
stocks

Chart of the Week: 3 undervalued US tech shares

Our US analysts’ top tech opportunities.
stocks

ASX payments utility looks overvalued

Australia’s invisible payments utility earns narrow moat yet valuation looks lofty.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,823.2071.40-0.80%
CAC 407,741.6627.55-0.35%
DAX 4024,912.73191.63-0.76%
Dow JONES (US)51,179.87341.41-0.66%
FTSE 10010,458.830.330.00%
HKSE23,785.79344.71-1.43%
NASDAQ27,538.6961.20-0.22%
Nikkei 22569,042.11993.60-1.42%
NZX 50 Index13,691.857.810.06%
S&P 5007,801.770.000.00%
S&P/ASX 2008,660.9066.80-0.77%
SSE Composite Index3,811.9030.29-0.79%

Market Movers